Glenn Goddard

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc, 40 Erie Street, Suite 130, Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Glenn Goddard:

Insider Reports Filed by Glenn Goddard

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Jan 3, 2024 1 -$158K 4 Jan 5, 2024 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Jan 1, 2024 2 $0 4 Jan 3, 2024 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Jan 4, 2023 1 -$90.3K 4 Jan 6, 2023 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2022 1 $0 4/A Mar 4, 2022 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Jan 1, 2022 5 -$114K 4 Mar 3, 2022 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Sep 7, 2021 3 -$576K 4 Sep 9, 2021 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Aug 30, 2021 15 -$4.21M 4 Sep 1, 2021 EVP, Chief Financial Officer
NTLA Intellia Therapeutics, Inc. Aug 5, 2021 5 -$2.64M 4 Aug 6, 2021 EVP, Chief Financial Officer